Phase
Condition
Dementia
Treatment
Resilient Together for Dementia
Clinical Study ID
Ages > 65 All Genders
Study Summary
Eligibility Criteria
Inclusion
PWD inclusion criteria are:
Recent (~1 month) chart documented ADRD diagnosis,
ADRD symptom onset after age 65 ,
cognitive assessment scores and symptoms consistent with early stage dementia, asdetermined by the Clinical Dementia Rating Scale scores of .5 or 1.0
cognitive awareness of his/her problems (as determined by the treating neurologist),and
ability to understand study and research protocol, as determined by a standardizedteach-back method assessment84.
Additional inclusion criteria for dyads are:
English speaking adults (18 years or older),
dyad lives together,
at least one partner endorses clinically significant emotional distress duringscreening (>7 on Hospital Anxiety and Depression scale subscales)
Exclusion
Exclusion Criteria:
patient is deemed inappropriate by the neurology team,
either partner has a co-occurring terminal illness,
patient was diagnosed with forms of dementia with clinical profiles that wouldpreclude participation (e.g., Frontotemporal Dementia- behavioral variant), asdetermined by treatment team.
Study Design
Study Description
Connect with a study center
Brain Injury Research Center at Mount Sinai
New York, New York 10029
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.